Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34195687.
- Also identified by DOI 10.1016/j.xcrm.2021.100324 and PMC identifier 8233690.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues<sup>1</sup> demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.
Medical subject headings
- Enterocolitis, Necrotizing
- Fetal Diseases
- Infant, Premature, Diseases